{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:56:45Z","timestamp":1784336205166,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,15]]},"DOI":"10.1093\/cid\/cit341","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T12:46:28Z","timestamp":1369313188000},"page":"543-551","source":"Crossref","is-referenced-by-count":103,"title":["Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii"],"prefix":"10.1093","volume":"57","author":[{"given":"Sharon C.-A.","family":"Chen","sequence":"first","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology and The Sydney Institute for Emerging Infections and Biosecurity, Sydney Medical School, University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony M.","family":"Korman","sequence":"additional","affiliation":[{"name":"Monash Infectious Diseases and Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Marriott","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, St Vincent's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Byth","sequence":"additional","affiliation":[{"name":"Research and Education Network, Westmead Hospital, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin","family":"Bak","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Royal Adelaide Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Currie","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department and Menzies School of Health Research, Royal Darwin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krispin","family":"Hajkowicz","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department and Menzies School of Health Research, Royal Darwin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Heath","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Royal Perth Hospital, and School of Medicine and Pharmacology, University of Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kidd","sequence":"additional","affiliation":[{"name":"Mycology Unit, SA Pathology at Women's and Children's Hospital, Adelaide"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J. H.","family":"McBride","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, James Cook University, Cairns"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieland","family":"Meyer","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology and The Sydney Institute for Emerging Infections and Biosecurity, Sydney Medical School, University of Sydney"},{"name":"Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Westmead Millennium Institute, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Microbiology, PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre and the Department of Infectious Diseases, Sir Charles Gairdner Hospital, Perth"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Geoffrey","family":"Playford","sequence":"additional","affiliation":[{"name":"Infection Management Services, Princess Alexandra Hospital, School of Medicine, University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania C.","family":"Sorrell","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology and The Sydney Institute for Emerging Infections and Biosecurity, Sydney Medical School, University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Australia and New Zealand Mycoses Interest Group (ANZMIG) Cryptococcus Studya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"key":"key\n\t\t\t\t20180328181700_CIT341C1","article-title":"Cryptococcus gattii infection, features that distinguish infection from C. neoformans","volume-title":"Cryptococcus: from human pathogen to model yeast","author":"Sorrell","year":"2011"},{"key":"key\n\t\t\t\t20180328181700_CIT341C2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cis529","article-title":"Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death","volume":"55","author":"Chen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinids\/20.3.611","article-title":"Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.","volume":"20","author":"Mitchell","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C7","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1128\/JCM.42.8.3865-3868.2004","article-title":"Cryptococcus infection in tropical Australia","volume":"42","author":"Jenny","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328181700_CIT341C8","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":", and the French Cryptococcosis Study Group. Determinants of disease presentation and outcome during cryptococcosis: the Crypto A\/D Study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328181700_CIT341C9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1086\/322597","article-title":"Cryptococcus in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","article-title":"Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy","volume":"42","author":"Robertson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France","volume":"19","author":"Lortholary","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328181700_CIT341C12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2009\/719659","article-title":"Clinical presentation, diagnosis and management of Cryptococcus gattii cases: lessons learned from British Columbia","volume":"20","author":"Galanis","year":"2009","journal-title":"Can J Dis Med Microbiol"},{"key":"key\n\t\t\t\t20180328181700_CIT341C13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/clinids\/14.5.1142","article-title":"Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii","volume":"14","author":"Mitchell","year":"1992","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.10-2964","article-title":"74-year-old man from the Pacific Northwest with fever and a lung mass","volume":"140","author":"Garrett","year":"2011","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180328181700_CIT341C15","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1086\/320524","article-title":"Cryptococcosis in patients with cancer","volume":"32","author":"Kontoyiannis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1445-5994.1993.tb04726.x","article-title":"Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes","volume":"23","author":"Fisher","year":"1993","journal-title":"Aust NZ J Med"},{"key":"key\n\t\t\t\t20180328181700_CIT341C18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2334-10-199","article-title":"A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam\u2014high prevalence of Cryptococcus neoformans var. grubii in the absence of underlying disease","volume":"10","author":"Chau","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C21","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1128\/JCM.42.10.4815-4817.2004","article-title":"In vitro antifungal susceptibility of Cryptococcus gattii","volume":"42","author":"Trilles","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328181700_CIT341C22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.02.018","article-title":"Epidemiological cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility","volume":"73","author":"Lockhart","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar puncture","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328181700_CIT341C24","first-page":"343","article-title":"Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously-healthy Melanesian adults in Papua New Guinea","volume":"87","author":"Lalloo","year":"1994","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t20180328181700_CIT341C25","doi-asserted-by":"crossref","first-page":"c47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin. Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/603554","article-title":"Dexamethasone in Cryptococcus gattii central nervous system infection","volume":"49","author":"Phillips","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/01.WNL.0000134677.29120.62","article-title":"Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis","volume":"63","author":"Lane","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328181700_CIT341C28","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1086\/424746","article-title":"Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman","volume":"39","author":"Einsiedel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C29","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328181700_CIT341C30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12281-011-0064-8","article-title":"Cryptococcus-related immune reconstitution inflammatory syndrome (IRIS): pathogenesis and its clinical implications","volume":"5","author":"Wiesner","year":"2011","journal-title":"Curr Fungal Infect Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/57\/4\/543\/17854236\/cit341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T18:24:08Z","timestamp":1645554248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/57\/4\/543\/349502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,22]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,5,22]]},"published-print":{"date-parts":[[2013,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit341","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,8,15]]},"published":{"date-parts":[[2013,5,22]]}}}